Eleftherios Paschalis

Ludwig Boltzmann Institute of Osteology

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

David Dempster

Professor

Columbia University

UNITED STATES

View details

Wen Qian

Research associate professor

University of Nebraska - Lincoln

UNITED STATES

View details

Nadja Fratzl-Zelman

Ludwig Boltzmann Institute of Osteology

AUSTRIA

View details

Oliver Pusch

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Ursula Föger-Samwald

Karl Landsteiner Privatuniversität für Gesundheitswissenschaften GmbH

AUSTRIA

View details

Jian Zhong

Stony Brook University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eleftherios Paschalis

Research Interests

Explore related searches

Contact this professor

Articles (11)

Bone intrinsic material and compositional properties in postmenopausal women diagnosed with long-term Type-1 diabetes

Nothobranchius furzeri, the Turquoise Killifish: A Model of Age-Related Osteoporosis

Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial

Vitamin C epigenetically controls osteogenesis and bone mineralization

Cortical bone material / compositional properties in growing children and young adults aged 1.5–23 years, as a function of gender, age, metabolic activity, and growth spurt

Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values

Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months

Bone properties in osteogenesis imperfecta: what can we learn from a bone biopsy beyond histology?

Mineral and organic matrix composition at bone forming surfaces in postmenopausal women with osteoporosis treated with either teriparatide or zoledronic acid.

Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women

Interplay between mineral crystallinity and mineral accumulation in health and postmenopausal osteoporosis

Collaborators (6)

David Dempster

Wen Qian

Nadja Fratzl-Zelman

Oliver Pusch

Ursula Föger-Samwald

Jian Zhong

Make your next move.